BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 2981269)

  • 1. Tac antigen-positive T cells activated in autologous mixed lymphocyte reaction regulate the generation of killer T cells against hapten-modified autologous cells.
    Kumagai S; Namiuchi S; Ozaki S; Sano H; Tsubata T; Suginoshita T; Imura H
    J Immunol; 1985 Feb; 134(2):711-7. PubMed ID: 2981269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
    Santoli D; Francis MK; Matera L
    Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction.
    Williams JM; Loertscher R; Cotner T; Reddish M; Shapiro HM; Carpenter CB; Strominger JL; Strom TB
    J Immunol; 1984 May; 132(5):2330-7. PubMed ID: 6325537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cytotoxic T cells in the rat mixed lymphocyte reaction is blocked by monoclonal antibody MRC OX-8.
    Green JR
    Immunology; 1984 Jun; 52(2):253-60. PubMed ID: 6234228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
    Strassmann G; Bach FH; Zarling JM
    J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous rosette-forming T cells regulate responses of T cells. Phenotypic and functional analysis of suppressor cells generated from autologous rosette-forming T cells after autologous mixed lymphocyte reactions.
    Kumagai S; Scher I; Green I
    J Clin Invest; 1981 Aug; 68(2):356-64. PubMed ID: 6455444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tolerance towards TNP entails down-regulation of an autoimmune attack.
    Zöller M; Andrighetto G
    Immunology; 1988 Feb; 63(2):205-12. PubMed ID: 2965095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte transformation induced by autologous cells. X. Soluble factors that generate cytotoxic T lymphocytes.
    Weksler ME; Moody CE; Ostry RF; Casazza BA
    J Exp Med; 1980 Aug; 152(2 Pt 2):284s-291s. PubMed ID: 6447745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential elimination of NK and CTL functions by anti-D44 monoclonal antibody.
    Calvo CF; Boumsell L; Kolb JP; Laffy B; Bernard A; Senik A
    J Immunol; 1984 May; 132(5):2345-9. PubMed ID: 6232316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated lympholysis of trinitrophenyl-derivatized autologous human cells: in vitro triggering by nonspecific signals.
    Friedman SM; Neyhard N; Chess L
    J Immunol; 1978 Feb; 120(2):630-7. PubMed ID: 304462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J; Rola-Pleszczynski M
    J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.